DIVI S LABORATORIES LTD vs IPCA LABORATORIES LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and IPCA LABORATORIES LTD (IPCALAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs IPCALAB on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
42.25
10.72
P/B ratio
5.41
0.44%
Dividend yield
0.23%
₹96.73
EPS
₹44.98

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
16.00%
22.00%
Return on capital
17.00%
33.00%
EBITDA margin
21.00%
24.32%
Net margin
12.27%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
15.85%
12.10%
Profit CAGR (3Y)
35.21%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹48,239 Cr
₹10,560 Cr
Revenue
₹9,646 Cr
₹2,568 Cr
Net profit
₹1,184 Cr
0.00
Debt / equity
0.10
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
IPCA LABORATORIES LTD
  • + ["Company has reduced debt."]
  • ["Stock is trading at 5.63 times its book value", "Company has a low return on equity of 13.1% over last 3 years."]
DIVI S LABORATORIES LTD full analysis IPCA LABORATORIES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.